University of Illinois at Chicago
Announcement of an Exempt Purchase
McKesson Specialty Care Distribution,Chicago, IL
- Amount: An estimated $1,680,000
- Terms: An estimated start date of 8/2/2021 through 6/30/2023
- Renewals: None
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Thursday, July 29, 2021
The University awarded a contract for Abecma.
Abecma (CAR-T therapy) is for treating multiple myeloma.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Abecma is CAR-T therapy for multiple myeloma. It is the only CAR-T therapy commercially available to treat this condition. UI Health currently has several patients who are candidates for Abecma. If this therapy is not made available, these patients will need to seek care at a different institution in order to receive this product.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.